Anti-Obesity Drugs and Beyond
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (31 December 2018) | Viewed by 4668
Special Issue Editor
2. Advanced Radiation Technology Institute (ARTI), Korea Atomic Energy Research Institute (KAERI), Jeonbuk 56212, Republic of Korea
3. Quantum Energy Chemical Engineering, University of Science and Technology, 217, Gajeong-ro, Yuseong-gu, Daejeon 34113, Republic of Korea
Interests: radiochemistry; radiation chemistry; nanomaterials; nanotechnology; nuclear energy; decommissioning and decontamination science and technology; environmental science and technology; radioactive isotopes; radiation; chemical engineering; separation technology; catalysis; biotechnology; education; sustainability; chemosensors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Obesity is one of the leading preventable causes of death worldwide, with increasing prevalence in adults and children. The World Health Organization (WHO) rates it as one of the most serious public health problems of the twenty-first century.
The aim of this Special Issue is for the better understanding, treatment, and prevention of obesity to improve the lives of those affected, and thereby to reduce the incidence of obesity-related diseases. We want to contribute to the cure and education of obesity through the sharing of scientific information on the latest developments in obesity among members of Korean Society for the Study of Obesity and other international societies. The journal publishes articles covering all aspects of obesity, in particular drug discovery, lipid metabolism, screening strategy, assay development, enzymes, public health, and Korean food. Nutritional, exercise, psychological, and public education aspects are also included in the studies.
This Special Issue includes research papers on the basics and medicine of obesity and obesity-related diseases, as well as the specific applications of chemistry, such as screening strategy and assay, biochemistry and biotechnology, genetics, and public education study. We think that solving the problems of obesity will be accompanied by various aspects of social problems in this special issue. The types of articles published include original articles, editorials, case reports, reviews, short communications, and letters to the editor.
Dr. Changhyun Roh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- obesity
- natural product
- Korean medicine
- lipid
- drug
- food
- public health
- prevention
- education
